OUR TECHNOLOGY

The Cour particle platforms provide a novel and highly specific immune targeting capability which may be applied to severe inflammatory modulation, and immune (antigen) tolerization.

Unmatched Breakthrough

The TIMP and IMP platforms are a truly novel opportunity unmatched by current in-market and pipeline alternatives which primarily consist of toxic immune suppressants. These platforms have far-reaching implications across a wide-spectrum of valuable therapeutic indications.

Immune Modifying
Nanoparticles (IMP)
For severe inflammation
IMP_3

The particle design starts with an FDA approved co-polymer – PLGA

The particles target/bind inflammatory cells (monocytes) and eliminate them through normal metabolism

Reduction in circulating monocytes prevents tissue damage

Tolerizing Immune Modifying

Nanoparticles (TIMP)

For autoimmune conditions
TIMP_3

While the IMP particle surface provides the immune uptake, the interior core can be loaded with antigen

Tolerizing IMPs (TIMPs) are programmable for a number of autoimmune conditions